China Obesity Management Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Obesity Management market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Obesity Management market. Detailed analysis of key players, along with key growth strategies adopted by Obesity Management industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Pfizer Inc

    • Merck Sharp & Dohme Corp

    • GlaxoSmithKline plc

    • Teva Pharmaceutical Industries Ltd

    • F Hoffmann-La Roche Ltd

    • Novo Nordisk

    • Currax Pharmaceuticals LLC

    • Sanofi-Aventis

    • Vivus

    • AstraZeneca

    • Bayer AG

    • Rhythm Pharmaceuticals, Inc

    By Type:

    • Peripherally Acting Drugs

    • Centrally Acting Drugs

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Obesity Management Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Obesity Management Market Size and Growth Rate of Peripherally Acting Drugs from 2016 to 2027

    • 1.3.2 China Obesity Management Market Size and Growth Rate of Centrally Acting Drugs from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Obesity Management Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • 1.4.2 China Obesity Management Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Obesity Management Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Obesity Management by Major Types

    • 3.4.1 Market Size and Growth Rate of Peripherally Acting Drugs

    • 3.4.2 Market Size and Growth Rate of Centrally Acting Drugs

    4 Segmentation of Obesity Management Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Obesity Management by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Obesity Management in Hospital Pharmacies

    • 4.4.2 Market Size and Growth Rate of Obesity Management in Retail Pharmacies

    5 Market Analysis by Regions

    • 5.1 China Obesity Management Production Analysis by Regions

    • 5.2 China Obesity Management Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Obesity Management Landscape Analysis

    • 6.1 North China Obesity Management Landscape Analysis by Major Types

    • 6.2 North China Obesity Management Landscape Analysis by Major End-Users

    7 Central China Obesity Management Landscape Analysis

    • 7.1 Central China Obesity Management Landscape Analysis by Major Types

    • 7.2 Central China Obesity Management Landscape Analysis by Major End-Users

    8 South China Obesity Management Landscape Analysis

    • 8.1 South China Obesity Management Landscape Analysis by Major Types

    • 8.2 South China Obesity Management Landscape Analysis by Major End-Users

    9 East China Obesity Management Landscape Analysis

    • 9.1 East China Obesity Management Landscape Analysis by Major Types

    • 9.2 East China Obesity Management Landscape Analysis by Major End-Users

    10 Northeast China Obesity Management Landscape Analysis

    • 10.1 Northeast China Obesity Management Landscape Analysis by Major Types

    • 10.2 Northeast China Obesity Management Landscape Analysis by Major End-Users

    11 Southwest China Obesity Management Landscape Analysis

    • 11.1 Southwest China Obesity Management Landscape Analysis by Major Types

    • 11.2 Southwest China Obesity Management Landscape Analysis by Major End-Users

    12 Northwest China Obesity Management Landscape Analysis

    • 12.1 Northwest China Obesity Management Landscape Analysis by Major Types

    • 12.2 Northwest China Obesity Management Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Pfizer Inc

      • 13.1.1 Pfizer Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck Sharp & Dohme Corp

      • 13.2.1 Merck Sharp & Dohme Corp Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 GlaxoSmithKline plc

      • 13.3.1 GlaxoSmithKline plc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Teva Pharmaceutical Industries Ltd

      • 13.4.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 F Hoffmann-La Roche Ltd

      • 13.5.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Novo Nordisk

      • 13.6.1 Novo Nordisk Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Currax Pharmaceuticals LLC

      • 13.7.1 Currax Pharmaceuticals LLC Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Sanofi-Aventis

      • 13.8.1 Sanofi-Aventis Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Vivus

      • 13.9.1 Vivus Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 AstraZeneca

      • 13.10.1 AstraZeneca Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Bayer AG

      • 13.11.1 Bayer AG Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Rhythm Pharmaceuticals, Inc

      • 13.12.1 Rhythm Pharmaceuticals, Inc Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Obesity Management Market Size and Growth Rate of Peripherally Acting Drugs from 2016 to 2027

    • Figure China Obesity Management Market Size and Growth Rate of Centrally Acting Drugs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Obesity Management Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure China Obesity Management Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Obesity Management Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Obesity Management Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Obesity Management

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Obesity Management by Different Types from 2016 to 2027

    • Table Consumption Share of Obesity Management by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Peripherally Acting Drugs

    • Figure Market Size and Growth Rate of Centrally Acting Drugs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Obesity Management by Different End-Users from 2016 to 2027

    • Table Consumption Share of Obesity Management by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Table China Obesity Management Production by Regions

    • Table China Obesity Management Production Share by Regions

    • Figure China Obesity Management Production Share by Regions in 2016

    • Figure China Obesity Management Production Share by Regions in 2021

    • Figure China Obesity Management Production Share by Regions in 2027

    • Table China Obesity Management Consumption by Regions

    • Table China Obesity Management Consumption Share by Regions

    • Figure China Obesity Management Consumption Share by Regions in 2016

    • Figure China Obesity Management Consumption Share by Regions in 2021

    • Figure China Obesity Management Consumption Share by Regions in 2027

    • Table North China Obesity Management Consumption by Types from 2016 to 2027

    • Table North China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure North China Obesity Management Consumption Share by Types in 2016

    • Figure North China Obesity Management Consumption Share by Types in 2021

    • Figure North China Obesity Management Consumption Share by Types in 2027

    • Table North China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table North China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure North China Obesity Management Consumption Share by End-Users in 2016

    • Figure North China Obesity Management Consumption Share by End-Users in 2021

    • Figure North China Obesity Management Consumption Share by End-Users in 2027

    • Table Central China Obesity Management Consumption by Types from 2016 to 2027

    • Table Central China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure Central China Obesity Management Consumption Share by Types in 2016

    • Figure Central China Obesity Management Consumption Share by Types in 2021

    • Figure Central China Obesity Management Consumption Share by Types in 2027

    • Table Central China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table Central China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Obesity Management Consumption Share by End-Users in 2016

    • Figure Central China Obesity Management Consumption Share by End-Users in 2021

    • Figure Central China Obesity Management Consumption Share by End-Users in 2027

    • Table South China Obesity Management Consumption by Types from 2016 to 2027

    • Table South China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure South China Obesity Management Consumption Share by Types in 2016

    • Figure South China Obesity Management Consumption Share by Types in 2021

    • Figure South China Obesity Management Consumption Share by Types in 2027

    • Table South China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table South China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure South China Obesity Management Consumption Share by End-Users in 2016

    • Figure South China Obesity Management Consumption Share by End-Users in 2021

    • Figure South China Obesity Management Consumption Share by End-Users in 2027

    • Table East China Obesity Management Consumption by Types from 2016 to 2027

    • Table East China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure East China Obesity Management Consumption Share by Types in 2016

    • Figure East China Obesity Management Consumption Share by Types in 2021

    • Figure East China Obesity Management Consumption Share by Types in 2027

    • Table East China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table East China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure East China Obesity Management Consumption Share by End-Users in 2016

    • Figure East China Obesity Management Consumption Share by End-Users in 2021

    • Figure East China Obesity Management Consumption Share by End-Users in 2027

    • Table Northeast China Obesity Management Consumption by Types from 2016 to 2027

    • Table Northeast China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Obesity Management Consumption Share by Types in 2016

    • Figure Northeast China Obesity Management Consumption Share by Types in 2021

    • Figure Northeast China Obesity Management Consumption Share by Types in 2027

    • Table Northeast China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table Northeast China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Obesity Management Consumption Share by End-Users in 2016

    • Figure Northeast China Obesity Management Consumption Share by End-Users in 2021

    • Figure Northeast China Obesity Management Consumption Share by End-Users in 2027

    • Table Southwest China Obesity Management Consumption by Types from 2016 to 2027

    • Table Southwest China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Obesity Management Consumption Share by Types in 2016

    • Figure Southwest China Obesity Management Consumption Share by Types in 2021

    • Figure Southwest China Obesity Management Consumption Share by Types in 2027

    • Table Southwest China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table Southwest China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Obesity Management Consumption Share by End-Users in 2016

    • Figure Southwest China Obesity Management Consumption Share by End-Users in 2021

    • Figure Southwest China Obesity Management Consumption Share by End-Users in 2027

    • Table Northwest China Obesity Management Consumption by Types from 2016 to 2027

    • Table Northwest China Obesity Management Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Obesity Management Consumption Share by Types in 2016

    • Figure Northwest China Obesity Management Consumption Share by Types in 2021

    • Figure Northwest China Obesity Management Consumption Share by Types in 2027

    • Table Northwest China Obesity Management Consumption by End-Users from 2016 to 2027

    • Table Northwest China Obesity Management Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Obesity Management Consumption Share by End-Users in 2016

    • Figure Northwest China Obesity Management Consumption Share by End-Users in 2021

    • Figure Northwest China Obesity Management Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Merck Sharp & Dohme Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme Corp

    • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme Corp

    • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme Corp

    • Table Product and Service Introduction of Merck Sharp & Dohme Corp

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Currax Pharmaceuticals LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Currax Pharmaceuticals LLC

    • Figure Sales and Growth Rate Analysis of Currax Pharmaceuticals LLC

    • Figure Revenue and Market Share Analysis of Currax Pharmaceuticals LLC

    • Table Product and Service Introduction of Currax Pharmaceuticals LLC

    • Table Company Profile and Development Status of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Company Profile and Development Status of Vivus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus

    • Figure Sales and Growth Rate Analysis of Vivus

    • Figure Revenue and Market Share Analysis of Vivus

    • Table Product and Service Introduction of Vivus

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Rhythm Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rhythm Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Rhythm Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Rhythm Pharmaceuticals, Inc

    • Table Product and Service Introduction of Rhythm Pharmaceuticals, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.